ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: TH-OR69

A Prediction Equation for Incident CKD Using Routinely Collected Data: The Kidney Disease Risk Equation (KDRE)

Session Information

Category: CKD (Non-Dialysis)

  • 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Sood, Manish M., Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • Dixon, Stephanie, Institute for clinical and evaluative sciences, London, Ontario, Canada
  • Rhodes, Emily, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Background

The identification of individuals at risk for incident CKD (eGFR < 60 ml/min, stage 3a) is an important first step for disease surveillance, monitoring, education and allocation of key therapies to reduce CKD progression. Despite recommendations, albuminuria measurements in appropriate individuals remains poor. As such, we set out to develop and validate a prediction equation for new onset CKD with and without an albumin creatine ratio (ACR).

Methods

Population-level administrative data cohort of 1,109,905 adults (>66 years old) from Ontario, Canada April 1, 2008 and December 31, 2017 with a minimum of 2 eGFR measures (one for baseline > 70 ml/min, one for outcome) were included. Prediction equations stratifying individuals with (n=191,690) and without (n=998,825) ACR were derived, internally validated by bootstrapping and externally validated in 122,144 (22,809 ACR, 99,335 non-ACR) individuals in Manitoba, Canada. The study outcome was a single eGFR measure < 60 mls/min/1.73 m2 with up to 10 years follow-up. In additional analyses, we examined two eGFR measures < 60 mls/min and a single eGFR < 45 ml/min as study outcomes.

Results

Among individuals (54.5% women, mean age 64 SD 7, mean baseline eGFR 82 SD 8, median ACR 1 IQR 1-3), an eGFR < 60 ml/min occurred in 37.2% during the follow-up. The final model including up to 6 variables (age, sex, baseline eGFR, hemoglobin, time from hypertension and diabetes mellitus diagnosis) yielded a 5-year c-statistics of 0.77 (no ACR) and 0.78 (with ACR) with excellent calibration. Model performance was similar in additional analyses and in an external validation.

Conclusion

An equation incorporating readily available and routinely collected administrative data variables can accurately predict the onset of CKD with or without ACR.